## Abstract The majority of, but not all, women with mutations in the BRCAI gene will be affected with breast or ovarian cancer by the age of 70. To establish whether known risk factors modify susceptibility to cancer in these women, we have studied the reproductive histories of 333 North American
Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier
β Scribed by Stephen G. Grant; Rubina Das; Christina M. Cerceo; Wendy S. Rubinstein; Jean J. Latimer
- Publisher
- Springer Netherlands
- Year
- 2007
- Tongue
- English
- Weight
- 737 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1219-4956
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Carriers of __BRCA1__ mutation face highly increased risk of breast and ovarian cancer and some studies with cell culture suggest that the encoded protein may be involved in oxidatively damaged DNA repair. However, no studies concerning a possible link between oxidatively damaged DNA an
## Abstract Early age at first birth and multiparity have been associated with a decrease in the risk of breast cancer in women in the general population. We examined whether this relationship is also present in women at high risk of breast cancer due to the presence of a mutation in either of the
Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population
## Abstract A systematic review of the literature was conducted to assess the outcomes of preventive interventions (prophylactic surgery, intensive cancer screening, and chemoprevention) in women who carry mutations in __BRCA__1/2 genes, in terms of reducing breast and gynaecological cancer inciden